tiprankstipranks
Biofrontera (BFRI)
NASDAQ:BFRI

Biofrontera (BFRI) Financial Statements

104 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently ―. The company's EPS TTM is $-13.102; its P/E ratio is -0.08; Biofrontera is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Mar 23Dec 22
Income Statement-
Total Revenue$ 7.91M$ 10.59M$ 8.90M$ 8.73M$ 10.14M
Gross Profit$ 7.91M$ 5.66M$ 4.33M$ 4.16M$ 4.89M
EBIT$ -3.54M-$ -6.20M$ -7.44M$ -2.69M
EBITDA$ -3.25M-$ -6.20M$ -7.18M$ -1.91M
Net Income Common Stockholders$ -10.44M$ 3.53M$ -6.34M$ -7.48M$ -2.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.82M$ 1.34M$ 3.42M$ 21.10M$ 27.76M
Total Assets$ 24.57M$ 27.93M$ 34.10M$ 41.97M$ 50.88M
Total Debt$ 3.67M$ 5.40M$ 2.81M$ 1.21M$ 1.35M
Net Debt$ -151.00K$ 4.06M$ -608.00K$ -19.89M$ -26.41M
Total Liabilities$ 26.42M$ 23.14M$ 33.07M$ 25.21M$ 27.01M
Stockholders Equity$ -5.42M$ 4.79M$ 1.04M$ 16.75M$ 23.88M
Cash Flow-
Free Cash Flow$ -3.38M--$ -3.71M$ -8.27M
Operating Cash Flow$ -3.33M$ -8.90M$ -2.00M$ -3.70M$ -8.27M
Investing Cash Flow$ 43.00K$ 73.00K$ 382.00K$ -14.00K$ -2.09M
Financing Cash Flow$ 5.80M$ 6.71M$ 591.00K-$ 0.00
Currency in USD

Biofrontera Earnings and Revenue History

Biofrontera Debt to Assets

Biofrontera Cash Flow

Biofrontera Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis